Haier Biomedical

Haier Biomedical is a major Chinese provider of biomedical low-temperature storage equipment and intelligent healthcare solutions. A subsidiary of Haier Group, the company developed proprietary ultra-low temperature refrigeration technology covering the -196°C to 8°C range, an area where the Chinese market had previously relied heavily on imports.

Company Overview

Founded in 2005 as a specialized division of Haier Group, Haier Biomedical initially focused on biomedical low-temperature storage equipment. The company successfully developed its proprietary cascade refrigeration technology and multi-stage mixed refrigerant systems, replacing imported equipment that had dominated the Chinese market. In 2019, the company listed on the Shanghai Stock Exchange’s STAR Market, becoming Qingdao’s first company to debut on this innovation-focused board.

The company has since transformed from a pure equipment manufacturer into an IoT-enabled solution provider. Its products and solutions now serve over 10,000 hospitals, research institutions, blood banks, and public health centers across more than 130 countries. Haier Biomedical maintains long-term partnerships with the World Health Organization (WHO) and UNICEF as a qualified vaccine storage equipment supplier.

Core Products

PIVAS Intelligent Integration System

The Pharmacy Intravenous Admixture Services (PIVAS) system represents Haier Biomedical’s flagship offering in hospital automation. Deployed at facilities including the Second Affiliated Hospital of Suzhou University (the first integrated intelligent PIVAS center in China), this solution automates the entire intravenous medication preparation workflow.

Key components include automatic labeling machines, injection dispensing robots, intelligent sorting systems, and automatic compounding equipment. The system integrates directly with Hospital Information Systems (HIS) to achieve zero-error medication preparation.

Smart Pharmacy Solutions

Haier Biomedical offers broad pharmacy automation covering outpatient, inpatient, and emergency dispensing scenarios. The product portfolio includes automatic packaging machines, self-service dispensing terminals, high-speed dispensing systems, and 24-hour unmanned pharmacy stations. These solutions have been deployed in over 300 medical institutions as of 2024.

Biobank Automation

Building on its low-temperature storage expertise, the company provides automated biobank solutions featuring robotic sample handling, digital twin management interfaces, and ultra-low temperature storage systems. These solutions serve major biobanks including the China Marrow Donor Program.

Technology & Innovation

Haier Biomedical holds over 263 patents, including 65 invention patents. The company’s R&D team has led or participated in drafting 9 national and industry standards for biomedical low-temperature storage, essentially covering all product categories in this field. Additionally, the company contributed to WHO international standards development.

Core technological competencies include cascade refrigeration system design, multi-stage refrigerant preparation, high-efficiency heat exchange technology, and precision temperature control. The company’s aerospace refrigeration technology has supported multiple Shenzhou spacecraft missions since 2011.

In 2023, Haier Biomedical received the China Industrial Award, becoming the only enterprise in the biosafety high-end equipment sector to earn this recognition.

Market Presence

In China’s biomedical low-temperature storage market, Haier Biomedical maintains the largest market share among domestic brands:

• Biobank storage: 50.5% market share
• Pharmaceutical and reagent storage: 27.3% market share
• Vaccine storage: 32.2% market share
• Blood storage: 21.4% market share

The smart pharmacy automation business has shown strong growth. In 2024, the company deployed its solutions in nearly 50 additional hospitals during the first half alone, with new orders growing 200% year-over-year.

Internationally, Haier Biomedical products are certified by WHO PQS (Performance, Quality and Safety) standards and serve healthcare systems across 130+ countries.

Key Milestones

• 2005: Company established as Haier’s biomedical division
• 2008: Provided biobank solutions for China Marrow Donor Program
• 2011: Obtained WHO PQS certification; aerospace refrigerator launched on Shenzhou-8
• 2013: Achieved -196°C to 8°C full temperature range coverage
• 2017: Launched IoT-enabled ultra-low temperature storage systems
• 2019: Listed on SSE STAR Market (688139.SH)
• 2023: Acquired Suzhou Houhong Technology (70% stake) to accelerate smart pharmacy expansion; received China Industrial Award
• 2024: Deployed first integrated intelligent PIVAS center at Suzhou University Hospital

Frequently Asked Questions

What is Haier Biomedical’s core business?

Haier Biomedical operates in two main segments: Life Science (biobank storage, laboratory automation) and Medical Innovation (smart pharmacy, PIVAS automation, blood safety). The company is China’s largest domestic manufacturer of biomedical low-temperature storage equipment and a growing player in hospital pharmacy automation.

Is Haier Biomedical related to Haier Group?

Yes, Haier Biomedical is a subsidiary of Haier Group, one of China’s largest consumer electronics and home appliance conglomerates. Haier Group is the actual controlling shareholder through its healthcare investment platform Yingkang Yisheng.

What certifications do Haier Biomedical products have?

Key certifications include WHO PQS certification for vaccine storage equipment, EU MDR 2017/745 compliance for select products, DIN 13277 certification for medical refrigerators, and various NMPA Class II/III medical device registrations in China.